Ausketan (002755.SZ): Obtained drug registration certificate for injection of Delasaxin Pumethamine

Wisdom Financial News APP News, Ausaicon (002755.SZ) announced that its wholly-owned subsidiary, Jiangsu Ausaicon Pharmaceutical Co., Ltd. (hereinafter referred to as the "subsidiary"), recently received the "Drug Registration Certificate" for injection use of delafloxacin pamoate issued by the National Medical Products Administration (hereinafter referred to as the "Drug Administration").